http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0876144-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d3b01fb021788dbfc32162e3ac5a12c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 1997-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542f7a4c9ace7bd3532800b7a582befe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ec78616723955b981eda26b273c131
publicationDate 2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0876144-B1
titleOfInvention Therapeutic anti-asthma agents containing ebselen
abstract The description relates to a therapeutic agent which comprises as the active agent a compound given by the formula (1) and/or (1') and/or a pharmaceutically acceptable salt thereof. The agent of the invention exhibits great effectiveness in cases of both immediate and later asthmatic reactions, especially the latter. Owing to its low toxicity, the agent of the invention can safely be prescribed for human beings.
priorityDate 1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11245343
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2PG45
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36423
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2RVI8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129408911
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1LIA5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47787
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6V115
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DBX6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49430
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01012
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96SQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2KIG5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812919

Total number of triples: 39.